Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Results
20 mars 2023 16h15 HE
|
Sanara MedTech Inc.
FORT WORTH, TX, March 20, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
Nemaura Medical Announces Receipt of Notice from Nasdaq
09 mars 2023 16h57 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, March 09, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call Dates
06 mars 2023 09h15 HE
|
Sanara MedTech Inc.
FORT WORTH, TX, March 06, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022
22 févr. 2023 09h15 HE
|
Sanara MedTech Inc.
FORT WORTH, TX, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
SeaStar Medical to Hold Business Update Conference Call on February 15, 2023
14 févr. 2023 16h05 HE
|
SeaStar Medical Holding Corporation
DENVER, Feb. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital...
SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
31 janv. 2023 08h00 HE
|
SeaStar Medical Holding Corporation
DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital...
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
26 janv. 2023 08h00 HE
|
Nemaura Medical, Inc
Nemaura to integrate its proBEATTM glucose sensors with HealthFleet’s proven RestoreHealth wellness program targeted at U.S. market LOUGHBOROUGH, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical,...
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
24 janv. 2023 08h00 HE
|
Nemaura Medical, Inc
Average weight loss of 3.7 pounds and an average BMI reduction of 0.6 after 10 weeks in initial patients LOUGHBOROUGH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:...
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
11 janv. 2023 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients
09 janv. 2023 08h25 HE
|
SeaStar Medical Holding Corporation
Building upon demonstrated clinical success, the pivotal study will evaluate the Selective Cytopheretic Device in adults with AKI requiring CKRT DENVER, Jan. 09, 2023 (GLOBE NEWSWIRE) --...